Chapter 6

The Growth Engine

The $2 billion 2030 revenue target implies about 21% annual growth for five years, down from the roughly 32% Vital Farms compounded over 2019–2025 [1]. Management has narrowed how it intends to get there: more households buying shell eggs more often, on a store base flat since 2023, while every non-core product — egg bites, ghee, tub butter, and now stick butter — has been discontinued [2]. Processing capacity was built ahead of demand that softened in 2026.

The target and the pace it requires

Vital Farms grew net revenue from $141M in 2019 to $759M in 2025 [3], a compound rate near 32% a year. The 2030 framework set at the December 2025 Investor Day — $2 billion in net revenue, a gross margin above 35%, and a 15–17% adjusted EBITDA margin [4] — asks for a slower but still demanding pace: roughly 21% a year off the 2025 base, the figure the CFO calls the company's "21% long-term CAGR" [5].

Loading...

Source: net revenue FY2019–FY2025 per company reported financials, with FY2025 also stated in the FY2025 Annual Report [6]; 2030 target per December 2025 Investor Day [7].

This is the second time the long-term goalpost has moved. Through 2024 the standing target was $1 billion in net revenue by 2027 at a 12–14% EBITDA margin [8]; the Investor Day both doubled the revenue ambition and lifted the margin ceiling to 15–17%. Raising a target while the business is compounding is a sign of confidence, but it also means the 2030 number is a newer, less-tested commitment than the headline suggests.

The 2026 reset makes the remaining path steeper than the 21% headline. After first-quarter velocities fell short, management cut fiscal-2026 revenue guidance to $775–800M — "at least 5% growth" — from the $900–920M set only three months earlier [9] [10]. Off an $800M 2026 base, reaching $2 billion by 2030 requires about 26% a year for the following four years — faster than the company's own long-run average and well above the pace it is guiding for this year. The plan is back-end-loaded, and 2026 spends one of its five years standing nearly still.

How growth happens now

Distribution is no longer the lever. Store count has been essentially flat at about 24,000 since 2023 [11], so revenue now grows by selling more through the same shelves: converting brand awareness into new households, and existing households into heavier buyers. The Investor Day action plan lays this out as six workstreams — brand awareness and household penetration, farmer recruitment and retention, processing capacity, retail partnerships, organization, and cash generation — with no product-innovation or new-category pillar among them [12].

No Results

Source: December 2025 Investor Day, revenue growth drivers [13]. The consumer-panel penetration reads 11.9%; the FY2025 10-K's Circana-based figure is 10.5% [14].

The scorecard shows the engine working: buy rate up 70% and velocity up 68% since 2020, with awareness pulling away from competitors. But the two levers are not moving in step. In 2024 the company added 2.3 million households (up 20%) and pushed penetration to 10.7% [15]; on the Circana basis it then edged down to 10.5% in 2025 even as revenue grew 25% [16]. Growth has leaned increasingly on buy rate rather than new triers — a shift management flagged as early as 2024, when it conceded its 30-million-household goal (originally 2027) would likely slip to 2028, "compensated" by buy-rate gains [17]. Deepening consumption per household has more headroom than widening the base — buy rate has already grown 70% — and it is the lever most exposed when a cheaper commodity substitute appears, which is what the Category and Moat analysis shows happened in 2026.

A narrowing portfolio

At the 2020 IPO, the growth story ran on four engines: household penetration, retail expansion, foodservice, and product innovation across new categories. Five years on, three of those four have been throttled back, and the portfolio has been pruned toward core eggs.

No Results

Sources: product history and discontinuations per FY2024 Annual Report, Note 6 [18]; butter wind-down per Q1 FY2026 10-Q, Note 23 [19].

The butter exit is the sharpest turn. In February 2025 the CFO took on the added title of Butter General Manager, reported butter sales up 11% for 2024, and called the line "a crucial cornerstone in our portfolio" and "an important piece of our growth strategy to meet our long-term financial goals" [20]. Fifteen months later, in May 2026, the company elected to wind butter down entirely, citing "increased complexity in our international supply chain and more volatile economics" and a decision to "focus on our core egg categories" [21]. Butter was small — roughly $6.1M of $187.2M in first-quarter 2026 revenue, about 3% [22] — so the exit is immaterial to revenue and, management says, margin-accretive and freeing bandwidth to "accelerate distribution in the company's core egg categories" [23]. What it removes is optionality: the one adjacency management had explicitly named as a growth pillar a year earlier.

Foodservice, an IPO pillar, has drifted the same way — from about 6% of net revenue in 2023 to 4% in 2024 and 3% in 2025, even as the dollar base grew [24]. There is a genuine ambivalence in the record here: the FY2025 10-K, filed in early 2026, still lists "Expand Our Portfolio" as a stated growth strategy and speaks of "strategic bets on larger-scale opportunities" [25], while the Investor Day plan and the butter decision point the other way. The revealed strategy is a concentrated shell-egg bet; the stated one still gestures at breadth.

Capacity built ahead of demand

On the supply side, the company chose to build first and fill later. It brought a third production line online at Egg Central Station in October 2025 and installed a second Moba grading system, then began building both lines of its second plant, Vital Crossroads in Seymour, Indiana, concurrently — explicitly, in the CEO's words, "to stay ahead of demand" and out of "confidence in future demand… rather than chasing" it [26]. The farmer network expanded to more than 600 farms, adding roughly 175 in 2025 alone [27], and by early 2026 exceeded 625 [28]. Entering 2026, the CEO described supply as "unconstrained," a reversal from the demand-outrunning-capacity problem of 2024 [29].

That sequencing is the growth engine's central risk. Building fixed capacity ahead of a premium product's demand works only if the demand shows up on schedule; when it slipped in early 2026, the pre-built base turned into the mechanism of the margin collapse the Cash Conversion chapter traced. Management then reversed course on the supply build: in May 2026 it reported that "growth fell short of our publicly announced guidance," cut planned 2026 capex to $70–75M from $140–150M [30], slowed construction at Vital Crossroads, and paused development of new accelerator farms [31]. It had already begun selling the land: about 526 acres of Indiana farmland bought for accelerator farms were classified for sale in 2025, with roughly 263 acres still to go [32].

2026 revenue guide midpoint ($M, cut from ~$910M)

788

2026 capex guide midpoint ($M, cut from ~$145M)

73

Accelerator-farm acres put up for sale

526

Sources: revised 2026 revenue guidance per Q1 FY2026 earnings release [33]; revised capex guidance per the release's Fiscal 2026 Outlook [34]; reset actions per Q1 FY2026 10-Q MD&A [35]; accelerator-farm land per Q1 FY2026 10-Q [36].

Slowing the build is the rational response to soft demand, and Vital Crossroads is still slated to open in 2027 [37]. But the whipsaw — build concurrently to stay ahead of demand, then within two quarters sell land and defer capacity — is itself information about how well management can forecast the demand its plan depends on.

Reading the engine

The refocusing has a defensible logic. Vital Farms' advantages — brand, the Certified Humane farmer network, retailer shelf economics — live in pasture-raised eggs, not in ghee or imported butter, and its adjacency record (egg bites, ghee, tub butter, butter) is a string of retreats. Concentrating capital and management attention on the category it leads, where household penetration is still only about 10.5% against a category near 97% [38], is a reasonable read of where the returns are.

The cost of that focus is that the $2 billion plan now has little to fall back on. Growth rests on one category's demand, driven mainly by getting existing households to spend more, and the fixed cost base has been pre-committed to it. That is precisely the configuration that produced the 2026 reset: when a cheaper commodity egg widened the price gap, there was no second category to cushion the volume miss, and a plant built ahead of demand carried its costs regardless. The bull case is operating leverage — if penetration and buy rate compound back toward 21%, the pre-built base delivers the 15–17% margin the plan promises, which is the recovery the Normalized Value analysis prices only partially. The bear case is that a single-category, demand-led plan with fixed costs already sunk is a narrower, more cyclical machine than a 21% five-year target implies.

What would change the read is observable and dated: household penetration resuming its climb toward the 30-million-household goal rather than stalling near 10–11%; buy rate holding its gains as price gaps normalize; and 2026 proving to be a one-year air pocket — a return to positive shell-egg volume growth in the second half — rather than a lower structural growth rate. If penetration stays flat and the plan continues to lean on buy rate alone, the honest conclusion is that the engine has one gear left, and the 2030 target is a demand forecast the company does not fully control.